EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting efflux pumps prevents the multi-step evolution of high-level resistance to fluoroquinolone in Pseudomonas aeruginosa

Xiao-Quan Yu iD, Hao Yang, Han-Zhong Feng, Jun Hou, Jun-Qiang Tian, Shao-Min Niu, Chong-Ge You, Xuan-Yu Tao, Si-Ping Zhang, Zhi-Ping Wang iD, Yong-Xing He iD

Microbiology Spectrum · 2025-04 · 13 (4)

DOI: 10.1128/spectrum.02981-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025-04. Verfasst von Xiao-Quan Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Urology, Gansu Province Clinical Research Center for urinary system disease, The Second Hospital & Clinical Medical School, Lanzhou Univ…. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Fluoroquinolones, Anti-Bacterial Agents, Membrane Transport Proteins. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotic resistance is emerging as a significant global health crisis, necessitating the urgent development of novel antibiotics or alternative therapies. Although it is recognized that bacteria require multiple mutations to develop resistance levels exceeding the mutant prevention concentration, the specific mutation combinations conferring high resistance have been largely undefined. Here, we investigated the multi-step evolution of fluoroquinolone resistance in Pseudomonas aeruginosa through experimental evolution and whole-genome sequencing coupled with proteomic approaches. We discovered that in low-dose and high-dose experimental evolution scenarios, combinations of mutations in the negative regulators of efflux pumps ( nfxB/mexR ) and DNA gyrases ( gyrA/gyrB ) contributed to the high-level resistance and some of these combinations were also prevalent in clinical isolates of P. aeruginosa . Notably, the selected nfxB mutation, which resulted in the overexpression of the MexCD-OprJ efflux pump, also exhibited collateral sensitivity to aminoglycosides and enhanced antibiotic tolerance. It was further revealed that the efflux pump inhibitor phenylalanine-arginine β-naphthylamide (PAβN) could effectively prevent evolution to high-level resistance for both laboratory and clinical P. aeruginosa strains. Our work highlights the critical role of efflux pump repressor-related mutations in the evolution of high-level antibiotic resistance and demonstrates the potential of targeting these mutations to impede the evolution toward high-level resistance. IMPORTANCE In this study, we examined the stepwise evolution of fluoroquinolone resistance in Pseudomonas aeruginosa using experimental evolution, whole-genome sequencing, and proteomic analyses. Our findings revealed that under both low-dose and high-dose conditions, mutations in efflux pump regulators ( nfxB / mexR ) and DNA gyrase genes ( gyrA / gyrB ) synergistically contributed to high-level resistance. These mutation combinations were not only observed in experimental settings but also detected in clinical isolates of P. aeruginosa . This work underscores the pivotal role of efflux pump repressor-related mutations in the progression to high-level antibiotic resistance. It also highlights the promise of targeting efflux pumps as a strategy to prevent the multi-step evolution of resistance in P. aeruginosa .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaFluoroquinolonesAnti-Bacterial AgentsMembrane Transport ProteinsDrug Resistance, BacterialDrug Resistance, Multiple, BacterialBacterial ProteinsMicrobial Sensitivity TestsPseudomonas InfectionsMutationWhole Genome SequencingHumansTranscription FactorsDNA-Binding ProteinsRepressor Proteins

Stichwörter der Autor:innen

Pseudomonas aeruginosaantimicrobial resistance evolutionefflux pump

Substanzen

FluoroquinolonesAnti-Bacterial AgentsBacterial ProteinsMembrane Transport ProteinsTranscription FactorsNfxB protein, Pseudomonas aeruginosaDNA-Binding ProteinsMexR protein, Pseudomonas aeruginosaRepressor Proteins

Autor:innen und Institutionen

  • Institute of Urology, Gansu Province Clinical Research Center for urinary system disease, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
  • Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations, School of Life Sciences, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
  • Laboratory Medicine Center, The Second Hospital of Lanzhou University, Lanzhou, Gansu, People's Republic of China.
  • Institute for Environmental Genomics, University of Oklahoma, Norman, Oklahoma, USA.

ORCID-Profile: Xiao-Quan Yu, Zhi-Ping Wang, Yong-Xing He

Zitieren

APA

Yu, X. Q., Yang, H., Feng, H. Z., Hou, J., Tian, J. Q., Niu, S. M., You, C. G., Tao, X. Y., Zhang, S. P., Wang, Z. P., & He, Y. X. (2025). Targeting efflux pumps prevents the multi-step evolution of high-level resistance to fluoroquinolone in Pseudomonas aeruginosa. Microbiology Spectrum, 13(4). https://doi.org/10.1128/spectrum.02981-24

Vancouver

Yu XQ, Yang H, Feng HZ, Hou J, Tian JQ, Niu SM, et al. Targeting efflux pumps prevents the multi-step evolution of high-level resistance to fluoroquinolone in Pseudomonas aeruginosa. Microbiology Spectrum. 2025;13(4). doi:10.1128/spectrum.02981-24

BibTeX
@article{Yu2025,
  author = {Yu, Xiao-Quan and Yang, Hao and Feng, Han-Zhong and Hou, Jun and Tian, Jun-Qiang and Niu, Shao-Min and You, Chong-Ge and Tao, Xuan-Yu and Zhang, Si-Ping and Wang, Zhi-Ping and He, Yong-Xing},
  title = {Targeting efflux pumps prevents the multi-step evolution of high-level resistance to fluoroquinolone in Pseudomonas aeruginosa},
  journal = {Microbiology Spectrum},
  year = {2025},
  volume = {13},
  number = {4},
  doi = {10.1128/spectrum.02981-24}
}
Kostenlos starten →